dpp 4 inhibitors and glp 1 agonists together GLP-1 receptor agonist versus DPP-4 inhibitor kidney and cardiovascular outcomes in clinical practice in type-2 diabetes fig2.gif
Description
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
DA Wallachs Zero Toll Medicine was an ambitious read into how AI and automation could make healthcare significantly cheaper.
Ozempic mimics a naturally occurring hormone in the body called glucagon-like peptide-1 (GLP1)
These drugs have attracted significant attention in both medical communities and the general public
Long-term effects of GLP-1 receptor agonists in type 2 diabetic patients: a retrospective real-life study in 131 patients
The gastrointestinal system is highly integrated with the central nervous system (CNS)
